Delisting risk
Tenaya Therapeutics
Develops gene therapies and small molecules for genetically defined heart diseases.
$0.6956
After-hours close+0.00 (+0.40%)
At close$0.6928(−0.35%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 25.03%54.31M sharesInsiders 23.07%50.06M sharesOther 51.90%112.63M shares
Shares outstanding 217.00M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F, as of Mar 31, 2026
108 holders · 54.31M shares · 26 new positions · 60 increased · 17 reduced · 21 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 8.48M | 3.91% | +8.48Mnew | May 15, 2026 |
| Millennium Management LLC | 5.46M | 2.51% | +840.9K | May 15, 2026 |
| Empery Asset Management, LP | 4.29M | 1.98% | −1.13M | May 8, 2026 |
| Citadel Advisors LLC | 4.20M | 1.94% | 0 | May 15, 2026 |
| Renaissance Technologies LLC | 3.71M | 1.71% | +1.86M | May 14, 2026 |
| BlackRock, Inc. | 3.70M | 1.71% | −244.6K | May 13, 2026 |
| Marshall Wace, LLP | 2.71M | 1.25% | +1.30M | May 15, 2026 |
| Kalehua Capital Management LLC | 2.00M | 0.92% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| TCG Opportunity III GP, LLCincl. The Column Group III, LP, Peter Svennilson +5 more | 23.10% | 49.31M | 13D | Feb 26, 2026 ↗ |
| Integrated Core Strategies (US) LLC | 5.20% | 11.58M | 13G | Aug 24, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| David V. Goeddel | director, 10 percent owner: | 49.31M | 22.73% | Mar 7, 2025 |
| Faraz Ali | director, officer: Chief Executive Officer | 417.8K | 0.19% | Aug 17, 2026 |
| Whittemore Tingley | officer: Chief Medical Officer | 214.1K | 0.10% | Aug 17, 2026 |
| Tomohiro Higa | officer: SVP, Finance | 118.3K | 0.05% | May 19, 2026 |
1 ten-percent owner holds 362.0K shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (6.94M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale · 3 lots | 5,787 | $0.7098 | 214,073 |
| Aug 17, 2026 | Faraz Alidirector, officer: Chief Executive Officer | Sale · 4 lots | 22,232 | $0.7097 | 417,782 |
| May 18, 2026 | Tomohiro Higaofficer: SVP, Finance | Sale | 1,485 | $0.7932 | 118,267 |
| May 18, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale | 3,121 | $0.7936 | 215,497 |
| May 18, 2026 | Faraz Alidirector, officer: Chief Executive Officer | Sale | 3,390 | $0.7934 | 440,014 |
| Feb 25, 2026 | Column Group Iii GP, LP10 percent owner | Sale | 1,862,545 | $0.5624 | 0 |
| Feb 24, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 658,440 | $0.6153 | 1,649,281 |
| Feb 23, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 306,000 | $0.5972 | 1,958,509 |
| Feb 20, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 523,734 | $0.6149 | 2,102,218 |
| Feb 17, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale · 2 lots | 3,518 | $0.6431 | 218,618 |
CongressHouse and Senate disclosures
Not reported.